
Bloomberg Surveillance TV: April 23, 2025
- Julian Emanuel, Chief Equity & Quantitative Strategist at Evercore ISI - Joachim Nagel, President at Deutsche Bundesbank - Torsten Slok, Chief Economist at Apollo Management - Dan Ives, Head Global Technology at Wedbush Securities Julian Emanuel, Chief Equity & Quantitative Strategist at Evercore ISI, offers his S&P 500 outlook amid further uncertainty about tariffs and corporate earnings. Joachim Nagel, President at Deutsche Bundesbank, joins from the IMF Spring Meetings to talk about the outlook for European and global economies as the US levies global tariffs. Torsten Slok, Chief Economist at Apollo Management, talks about the outlook for a US recession this year. Dan Ives, Head Global Technology at Wedbush Securities, breaks down Tesla earnings.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
an hour ago
- Business Insider
Evercore ISI Remains a Hold on Sarepta Therapeutics (SRPT)
Evercore ISI analyst Gavin Clark-Gartner maintained a Hold rating on Sarepta Therapeutics (SRPT – Research Report) today and set a price target of $28.00. The company's shares closed today at $21.56. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Clark-Gartner covers the Healthcare sector, focusing on stocks such as Sarepta Therapeutics, Rocket Pharmaceuticals, and Ascendis Pharma. According to TipRanks, Clark-Gartner has an average return of 4.1% and a 45.16% success rate on recommended stocks. In addition to Evercore ISI, Sarepta Therapeutics also received a Hold from Goldman Sachs's Salveen Richter in a report issued today. However, on the same day, TD Cowen maintained a Buy rating on Sarepta Therapeutics (NASDAQ: SRPT).


Business Insider
an hour ago
- Business Insider
Closing Bell Movers: Futures extend decline amid Middle East tension
In the opening hour of the evening session, the bearish turn seen in U.S. equity trading on Tuesday has carried through to a negative open in the futures market – S&P 500 e-minis and Dow Industrials are down 0.3% while Nasdaq 100 is off by 0.4%. In commodities, WTI Crude Oil is up another 0.6%, approaching $74 per barrel. In metals, Gold is little changed just above $3,400 per ounce, while Silver is consolidating its breakout to a fresh high above $37 per ounce. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Increasingly bellicose posturing out of the White House is being attributed to Tuesday's sell-off, with President Trump posting on Truth Social demands of 'unconditional surrender' and warning Tehran that the U.S. 'patience is wearing thin'. Consumer Discretionary and Health Care sectors were the worst performers on the S&P 500, while Energy was the sole sector in the green thanks to a lift in oil prices. Residential solar names First Solar and Enphase were the sector's biggest losers as analysts warned that the Senate budget bill is negative for the industry. Jabil was the biggest gainer after the company reported a Q3 earnings beat and raised its guidance on top and bottom line. Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER – DOWN AFTER EARNINGS – Vistagen Therapeutics (VTGN) down 4.2% La-Z-Boy (LZB) down 0.4% ALSO LOWER – Bitdeer Technologies (BTDR) down 5.9% after convertible debt offering Willamette Valley Vineyards (WVVI) down 2.1% after mixed shelf offering Zoetis (ZTS) down 0.2% after Stifel downgrade


CNBC
an hour ago
- CNBC
European markets to open mostly lower as Fed decision, Middle East conflict in focus
A view of the London skyline during sunrise looking east, including Canary Wharf, from Horizon 22, London's highest free viewing platform. Picture date: Friday September 15, 2023. Yui Mok - Pa Images | Pa Images | Getty Images Good morning and welcome to CNBC's live blog covering European financial market action and the latest regional and global business news, data and earnings. Futures data from IG suggests sharp falls across European markets at the open, with London's FTSE looking set to open 52 points lower at 8,827, Germany's DAX down 245 points at 23,447, France's CAC 40 down 75 points at 7,665 and Italy's FTSE MIB 329 points lower at 39,568. Global investors continue to assess ongoing fighting between Israel and Iran tensions after continued missile attacks and airstrikes on Monday. Oil prices have risen on supply worries, and the price of gold has also increased amid a flight to safe haven assets after the conflict erupted last week. Those prices rose further overnight, and U.S. stock futures turned lower, after U.S. President Donald Trump signaled a further escalation in attacks could be coming as he urged Iranians to evacuate Tehran. — Holly Ellyatt The U.S. Federal Reserve's latest monetary policy decision is due Wednesday afternoon. Fed funds futures are pricing in an almost 100% likelihood that the central bank will keep rates unchanged, as per CME's FedWatch tool, despite U.S. President Donald Trump's continued pressure on Fed Chief Jerome Powell for a rate cut. Television stations broadcast Jerome Powell, chairman of the U.S. Federal Reserve, speaking after a Federal Open Market Committee meeting, on the floor of the New York Stock Exchange on May 7, 2025. Michael Nagle | Bloomberg | Getty Images Investors will be keeping a close eye on Powell's post-meeting comments and for the central bank policymakers' forecast on rate policy, as the Federal Open Market Committee will be sharing members' "dot plot" of rate expectations. In Europe, U.K. investors will be keeping a close eye on inflation data from the U.K. for May, with economists expecting the consumer price index to have risen 3.4% in the year to May. Elsewhere, Sweden's Riksbank publishes its latest interest rate decision on Wednesday. There are no other data or major earnings reports due. — Holly Ellyatt